Ketoprofen and Zoledronic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ketoprofen (ketoprofen) and Zoledronic (zoledronic acid). Common drug interactions include thrombocytopenia among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Ketoprofen and Zoledronic. It is created by eHealthMe based on reports of 99 people who take the same drugs from the FDA, and is updated regularly.

What is Ketoprofen?

Ketoprofen has active ingredients of ketoprofen. It is often used in pain. eHealthMe is studying from 15,048 Ketoprofen users. Check the latest studies of Ketoprofen.

What is Zoledronic?

Zoledronic has active ingredients of zoledronic acid. eHealthMe is studying from 29,812 Zoledronic users. Check the latest studies of Zoledronic.



On Aug, 09, 2026

99 people who take Ketoprofen and Zoledronic together, and have interactions are studied.

Ketoprofen and Zoledronic drug interactions.

What are the common drug interactions of Ketoprofen and Zoledronic, by gender? *:

female:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Tuberculous pleurisy (an inflammation of lung covering plura by mycobacterium tuberculosis)
  3. Upper respiratory tract infection
  4. Abdominal wall abscess (abdominal wall infection)
  5. Asthma
  6. Blood pressure decreased
  7. Bone abscess
  8. C-reactive protein increased
  9. Compression fracture (fracture due to pressure caused by injury)
  10. Cyst (a closed sac)

male:

  1. Drug ineffective
  2. Constipation
  3. Peripheral swelling
  4. Sudden death
  5. Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
  6. Pneumonia influenzal (the flu with pneumonia)
  7. Metastases to lymph nodes (cancer spreads to lymph node)
  8. Overdose
  9. Fracture
  10. Pneumonitis (inflammation of the walls of the alveoli in the lungs)

What are the common drug interactions of Ketoprofen and Zoledronic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anaemia (lack of blood)
  2. Constipation
  3. Nausea (feeling of having an urge to vomit)
  4. Vomiting

30-39:

n/a

40-49:

  1. Diarrhoea
  2. Dyspnoea (difficult or laboured respiration)
  3. General physical condition
  4. Renal impairment (severely reduced kidney function)
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  6. Vomiting
  7. Abdominal wall abscess (abdominal wall infection)
  8. Arthralgia (joint pain)
  9. Blood pressure decreased
  10. Bone abscess

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Constipation
  3. Decreased appetite
  4. Drug ineffective
  5. Dyschezia (difficulty in defecating)
  6. Pneumonia
  7. Weight decreased
  8. Affective disorder (mental disorder)
  9. Depressed mood
  10. Neuropathy peripheral (surface nerve damage)

60+:

  1. Hypoxia (low oxygen in tissues)
  2. Pathological fracture (broken bone caused by disease)
  3. Overdose
  4. Fracture
  5. Constipation
  6. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  7. Death
  8. Anaemia (lack of blood)
  9. Diarrhoea
  10. Osteitis (a general term for inflammation of bone)

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 25 people, 25.25%
  2. Multiple Myeloma (cancer of the plasma cells): 21 people, 21.21%
  3. Constipation: 14 people, 14.14%
  4. Neuropathy Peripheral (surface nerve damage): 13 people, 13.13%
  5. Breast Cancer: 12 people, 12.12%
  6. Insomnia (sleeplessness): 11 people, 11.11%
  7. Nail Abnormalities (abnormal nail): 9 people, 9.09%
  8. Adverse Event: 9 people, 9.09%
  9. Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 6 people, 6.06%
  10. Breast Cancer Recurrent: 5 people, 5.05%

* Approximation only. Some reports may have incomplete information.

Do you take Ketoprofen and Zoledronic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ketoprofen and Zoledronic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ketoprofen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zoledronic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ketoprofen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zoledronic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ketoprofen and zoledronic acid (the active ingredients of Ketoprofen and Zoledronic, respectively), and Ketoprofen and Zoledronic (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: